BioCentury
ARTICLE | Clinical News

Onsolis regulatory update

May 20, 2013 7:00 AM UTC

BioDelivery disclosed in its 1Q13 earnings that it and Meda submitted a proposal to FDA in March to relaunch pain drug Onsolis fentanyl in the U.S., with a potential launch slated for next half. Last ...